Rituximab added to an intensified salvage chemotherapy program followed by autologous stem cell transplantation improved the outcome in relapsed and refractory aggressive non-Hodgkin lymphoma

By Sieniawski Michal   Staak Oliver   Glossmann Jan-Peter   Reineke Thorsten   Scheuß Helena   Diehl Volker   Engert Andreas   Josting Andreas  

Annals of Hematology, Vol. 86, Iss. 2, 2007-02 ,pp. : 107-115

Springer Publishing Company

Access to resources Recommend Favorite

Myelofibrosis with myeloid metaplasia in a patient with relapsed Hodgkin's lymphoma who underwent autologous hematopoietic stem cell transplantation

By Massa Federico Sackmann   Rolón Juliana Martinez   Pavlovsky Santiago  

Hematology, Vol. 12, Iss. 6, 2007-12 ,pp. : 487-488

Maney Publishing

Access to resources Recommend Favorite

Predictive value of ¹⁸F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin's lymphoma prior to and after autologous stem cell transplantation

By Qiao Wenli   Zhao Jinhua   Wang Chun   Wang Taisong   Xing Yan  

Hematology, Vol. 15, Iss. 1, 2010-02 ,pp. : 21-27

Maney Publishing

Access to resources Recommend Favorite

Outpatient reduced-intensity allogeneic stem cell transplantation for patients with refractory or relapsed lymphomas compared with autologous stem cell transplantation using a simplified method

By Gutiérrez-Aguirre Cesar   Ruiz-Argüelles Guillermo   Cantú-Rodríguez Olga   González-Llano Oscar   Jaime-Pérez José   García-Rodríguez Fernando   López-Otero Avril   Herrera-Garza José   Gómez-Almaguer David  

Annals of Hematology, Vol. 89, Iss. 10, 2010-10 ,pp. : 1045-1052

Springer Publishing Company

Access to resources Recommend Favorite

Rituximab therapy increased post-transplant cytomegalovirus complications in Non-Hodgkin’s lymphoma patients receiving autologous hematopoietic stem cell transplantation

By Lee Ming-Yang  

Annals of Hematology, Vol. 87, Iss. 4, 2008-04 ,pp. : 285-289

Springer Publishing Company

Access to resources Recommend Favorite